Neoplasms Clinical Trials

There are 17 registered clinical trials for Neoplasms in the TrialLens index.

Trials (17)

• A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer Phase 1 · Boehringer Ingelheim
• A Study of MEHD7945A and Cobimetinib in Patients With Locally Advanced or Metastatic Cancers With Mutant KRAS Phase 1 · Genentech, Inc.
• Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors Phase 1 · Boehringer Ingelheim
• Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous Thromboembolism N/A · Assistance Publique - Hôpitaux de Paris
• A Dose-Escalation Study of RO5083945 in Patients With Metastatic and/or Locally Advanced Malignant Epidermal Growth Factor Receptor (EGFR)+ Solid Tumors. Phase 1 · Hoffmann-La Roche
• Exercise to Prevent AnthrCycline-based Cardio-Toxicity Study N/A · Nova Scotia Health Authority
• Finding My Way-UK: Promoting Positive Psychological Outcomes in People Living With and Beyond Curatively Treated Cancer N/A · Edge Hill University
• Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004) Phase 1/2 · Merck Sharp & Dohme LLC
• ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies N/A · University Hospital, Caen
• A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent Phase 2 · Adherex Technologies, Inc.
• Biodistribution Study of CMD-193 in Patients With Advanced Tumours Expressing the Lewis-Y Antigen Phase 1 · Ludwig Institute for Cancer Research
• Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1 Phase 2 · GlaxoSmithKline
• Phase I, Open-Label, Dose-Escalation Study of AZD4877 in Solid Tumors Phase 1 · AstraZeneca
• A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors. Phase 1 · Hoffmann-La Roche
• Detecting Tumor Specific Amplitude-modulated Frequencies of Cancer Patients N/A · Southern Medical University, China
• Dose Escalation Study of TriN2755 in Advanced Solid Tumors and Sarcomas Phase 1 · Trin Therapeutics GmbH
• An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy Phase 2 · Haihua Yuan

Related landscapes

• Phase 1/2 Neoplasms
• N/A Neoplasms
• Phase 2 Neoplasms
• Phase 1 Neoplasms

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.